EVH - Evolent Health, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue627,063434,950254,18896,878
Cost of Revenue398,714263,852152,37757,398
Gross Profit228,349171,098101,81139,480
Operating Expenses
Research Development----
Selling General and Administrative229,418195,666147,73670,986
Non Recurring----
Others----
Total Operating Expenses672,647491,886317,337135,550
Operating Income or Loss-45,584-56,936-63,149-38,672
Income from Continuing Operations
Total Other Income/Expenses Net-8,567-19,468-174,384381,961
Earnings Before Interest and Taxes-45,584-56,936-63,149-38,672
Interest Expense-5,484-3,636-247-247
Income Before Tax-54,151-76,404-237,533343,289
Income Tax Expense40-6,637-10,75523,475
Minority Interest45,53235,427209,588285,238
Net Income From Continuing Ops-54,191-69,767-226,778319,814
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-52,658-60,665-159,742332,494
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-52,658-60,665-159,742330,310